Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This prospective observational study investigates the potential of point-of-care ultrasonography of the optic nerve sheath diameter (ONSD) to rule out papilledema in patients with suspected hypertensive emergency. The primary focus is on assessing ONSD sensitivity in identifying papilledema (hypertensive retinopathy grade 4), while secondary endpoints include hypertensive retinopathy grade 3, hypertensive encephalopathy, and the need for intravenous rapid-acting medications to lower elevated blood pressure. This study aims to determine the diagnostic characteristics of this procedure for the diagnosis of hypertensive retinopathy, thus assessing its potential as a screening tool to rule out hypertensive retinopathy by the acute internal medicine doctor.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Optic Nerve Sheath Diameter | Diagnostic Test | Point of care ultrasonography of the optic nerve sheath diameter |
| Measure | Description | Time Frame |
|---|---|---|
| Papilledema | Sensitivity of ONSD > 5mm for diagnosis of papilledema | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Hypertensive retinopathy grade 3 & 4 combined | Sensitivity/specificity of the ONSD for hypertensive retinopathy grade 3 & 4 combined | 2 years |
| Hypertensive encephalopathy | Sensitivity/specificity of the ONSD for hypertensive encephalopathy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients presenting to the emergency department with suspected hypertensive emergency.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Tessa Mulder, MD | Contact | +31 71 52 96151 | t.a.mulder@lumc.nl | |
| Martijn Bauer, MD, PhD | Contact | +31 71 52 62381 | m.p.bauer@lumc.nl |
| Name | Affiliation | Role |
|---|---|---|
| Tessa Mulder, MD | Leiden University Medical Center | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000096003 | Hypertensive Crisis |
| D010211 | Papilledema |
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D009901 | Optic Nerve Diseases |
| D003389 | Cranial Nerve Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 years |
| Rapid acting medications administered intravenously to lower the elevated blood pressure | Sensitivity/specificity of the ONSD for the need for rapid acting medications administered intravenously to lower the elevated blood pressure | 2 years |
| Presence of a bulging optic nerve disc and/or crescent sign found by ultrasonography of the optic nerve | Diagnostic characteristics for the presence of a bulging optic nerve disc and/or crescent sign for above mentioned diagnoses (papilledema, hypertensive retinopathy grade 3&4 combined, hypertensive encephalopathy, need for rapid acting intravenous medications to lower elevated bloodpressure). | 2 years |
| D009422 |
| Nervous System Diseases |
| D005128 | Eye Diseases |